BioCardia Inc logo

BCDA - BioCardia Inc News Story

$4.01 -0.3  -7.6%

Last Trade - 12/04/21

Sector
Healthcare
Size
Micro Cap
Market Cap £47.7m
Enterprise Value £32.1m
Revenue £106k
Position in Universe 5462nd / 6841

BRIEF-BioCardia Update On Cell Therapy Product Development And 2021 Milestones

Tue 2nd February, 2021 1:37pm
Feb 2 (Reuters) - BioCardia Inc  BCDA.O :
    * BIOCARDIA UPDATE ON CELL THERAPY PRODUCT DEVELOPMENT AND
2021
MILESTONES
    * BIOCARDIA INC - BCDA-01 TRIAL IS EXPECTED TO HAVE ITS NEXT
PRESPECIFIED INDEPENDENT DATA SAFETY MONITORING BOARD REVIEW IN
EARLY Q3 2021
    * BIOCARDIA INC - FIRST PATIENT ENROLLED IN BCDA-02 TRIAL IS
EXPECTED IN Q1 WITH ROLL IN COHORT SAFETY DATA IN 2021
    * BIOCARDIA - WORKING TO RESOLVE OUTSTANDING ISSUES WITH FDA
TO
ENABLE CO TO MOVE FORWARD WITH NK1R+ MSC PROGRAM AND TARGET IND
ACCEPTANCE IN 2021
    * BIOCARDIA INC - TARGET IND ACCEPTANCE IN 2021 FOR BCDA-04
TRIAL

Source text for Eikon:  ID:nGNXM9g5r 
Further company coverage:  BCDA.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.